This protocol is judged by an institutional evaluation board, an independent team that critiques any medical trials involving humans. If a research consists of a Timetable I drug, when the board approves the protocol as moral, the scientists need to make an application for an investigational new drug (IND) number within the FDA.Drugs may additional